JUN 28, 2017 10:30 AM PDT

WEBINAR: Variant detection in cell-free DNA from NSCLC using NGS

SPONSORED BY: Thermo Fisher Scientific Ion Torrent
5 25 3494

  • Associate Professor, Princess Margaret Cancer Centre
      Dr. Stockley is a clinical molecular geneticist and Associate Director of the Molecular Diagnostics Division at the University Health Network, providing leadership within the two divisional molecular diagnostic laboratories. She is a member of the Board of Directors of the Canadian College of Medical Geneticists, the Canadian representative to the International Organization for Standardization Working Group on Molecular Diagnostics, and a member of the Laboratory Accrediation Advisory Panel for the Institute for Quality Management in Healthcare. Dr. Stockley's interests include the development of novel molecular diagnostic testing using high-throughput methodologies, and implementation and evaluation of genetic and genomic tests, particularly for acquired and inherited cancers.


    DATE: June 28, 2017
    TIME: 10:30am PT, 1:30pm ET

    This webinar will describe the implementation of the Oncomine Lung cfDNA Assay from Thermo Fisher Scientific in the Advanced Molecular Diagnostic Laboratory at the Princess Margaret Cancer Centre in Toronto, Canada.  Dr. Stockley will describe the Princess Margaret experience using the Oncomine Lung cfDNA assay for detection of variants in circulating cell-free DNA from non-small cell lung cancer (NSCLC) samples.  The usefulness of detection of the EGFR T790M resistance mutation in cell-free DNA, and comparison to EGFR T790M detection by droplet digital PCR (ddPCR), will also be presented. 

    Learning objectives:

    • Understand the utility of the Oncomine Lung cfDNA for testing of cell-free DNA for NSCLC
    • Describe the advantages of using the Oncomine Lung cfDNA for detection of the EGFR T790M resistance mutation as compared to droplet digital PCR (ddPCR

    For RUO.  Not for use in diagnostic procedures.

    Show Resources
    Loading Comments...